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TRANSLATIONAL MEDICINE AT THE INTERSECTION OF
EVIDENCE-BASED MEDICINE AND NARRATIVE MEDICINE
Alberto C. S. Costa1
The content of this editorial is based on the
keynote speech I delivered at the Sixth International
Congress on Health Issues in Childhood and
Adolescence (http://congressocisca.com.br/) held at
the School of Public Health, University of São Paulo,
Brazil, on May 2015. On that occasion, I told two parallel
stories to the audience.  First, I talked about the many,
sometimes-misguided decisions that made me into the
professional researcher in the field of Translational
Medicine that I am today. Second, I described some of
the historical landmarks that led to the development
of the field of Evidence Based Medicine, and the
consequences of this development for the current
teaching and practice of medicine.
I received my medical degree from the State
University of Rio de Janeiro (Universidade Estadual de
Rio de Janeiro – UERJ) in 1986. When I enrolled at the
School of Medicine at UERJ, I was naïve enough not to
know that that specific Medical School represented one
of the last bastions of “traditional medicine” in Brazil,
which is now known as Experience-based Medicine.  For
example, teaching at the State University of Rio de
Janeiro was still based on traditional medical disciplines
(i.e., anatomy, physiology, pharmacology, pathology,
etc.), compared with the more contemporary medical
curriculum at the Federal University of Rio de Janeiro
(Universidade Federal do Rio de Janeiro – UFRJ), which
was based on systems. Although considered outdated
now, the traditional approach used by my old medical
school produced an infernal repetition of the same issues
from semester to semester, but it also guaranteed that
the information ultimately made an indelible mark in
the brain of the poor student. In addition, the curriculum
of UERJ was completely rigid, and did not allow the
student to “stray” into non-medical disciplines. In
contrast, the UFRJ allowed the student who had interests
other than medicine to take classes in subjects other
than those offered by the medical curriculum. Such
rigidity at my medical school was also a torture for me,
given that I was a student who had come from a federal
technical school (CEFET-RJ) and, since day one, had
the dream of becoming a physician-scientist.
UERJ was also Brazil’s most traditional of Brazil’s
traditional medical schools in other ways. For example,
most of the third year of medical school at UERJ was
dedicated to medical propaedeutics (or propedeutics),
and we spent most of the day in medical wards of
various specialties, learning to collect medical histories
and doing physical exams. Initially, this was also a
nightmare for me. Nevertheless, exactly because I had
no other options, little by little, I became more and
more comfortable at interacting with patients, and
skillful in recognizing signs and symptoms of various
diseases and disorders that can affect human beings,
which are skills that serve me well until this day.
During my clinical rotations, I had excellent
mentors, such as Drs. Jose Augusto Fernandes Quadra,
Fernando Bevilacqua, Jayme Landmann and Pedro
Sampaio. All these individuals had in common an
immense amount of knowledge, tremendous passion
for the art of medicine, and egos commensurate with
these attributes. They rarely allowed the student or
resident to question their clinical assessments,
regardless of whether such opinions were based on
scientific evidence or not (except, perhaps, Dr. Quadra;
but that man was never wrong anyway...). “Clinical
knowledge is king!” This is what they used to say.
In 1987, I was ecstatic because I thought I had
finally abandoned medicine after six torturous years of
medical school. I had been accepted into the graduate
program at the Institute of Biophysics Carlos Chagas
Filho at UFRJ (IBCCF-UFRJ), where I would devote
myself completely to the practice of basic science.
Despite having taken classes with luminary figures such
as Professor Aristides Leão and the late Professor Carlos
Chagas Filho himself, I noticed immediately a huge
difference in the approach to teaching at the IBCCF-
UFRJ compared with my experience in medical school.
In this new environment, the student had been always
encouraged to question everything that was being said.
Information was always presented as potentially
falsifiable; which is typical of the scientific attitude.
After a year and a half taking classes and learning
laboratory techniques as a graduate student at IBCCF-
UFRJ, I spent two and a half years on a research
fellowship at the Department of Pharmacology in the
University of Maryland. This was followed by my return
to the IBCCF in 1991 to defend my doctoral thesis in
Biological Sciences (Biophysics). From there, I went to
Baylor College of Medicine, in Texas, where I did four
and a half years of postdoctoral training in Neuros-
cience.
 In 1992, the article “Evidence-based medicine.
A new approach to teaching the practice of medicine”
was published in the Journal of the American Medical
Association, JAMA1. After some pushback from leading
practitioners of Experience-based Medicine, this
emerging field underwent rapid ascension among the
medical establishment.  Below are some comments
extracted from the editorial published in the British
Journal of Medicine in 1996 by Sackett et al.2, which
addresses some of the initial criticism directed against
the original article:
• “Evidence based medicine is the conscientious,
explicit, and judicious use of current best evidence in
making decisions about the care of individual patients.
The practice of evidence based medicine means
integrating individual clinical expertise with the best
available external clinical evidence from systematic
research. By individual clinical expertise we mean the
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proficiency and judgment that individual clinicians
acquire through clinical experience and clinical practice.
Increased expertise is reflected in many ways, but
especially in more effective and efficient diagnosis and
in the more thoughtful identification and compassionate
use of individual patients’ predicaments, rights, and
preferences in making clinical decisions about their care.
By best available external clinical evidence we mean
clinically relevant research, often from the basic
sciences of medicine, but especially from patient
centred clinical research [...].”
• “External clinical evidence both invalidates
previously accepted diagnostic tests and treatments
and replaces them with new ones that are more
powerful, more accurate, more efficacious, and safer.”
[Falsifiability!]
• “Good doctors use both individual clinical
expertise and the best available external evidence, and
neither alone is enough.”
 In 1996, I landed my first independent appoint-
ment as a Research Scientist at The Jackson Laboratory,
in Maine, an institution that was at the center of the
genetic revolution and that has played an integral part
to translational medicine.
In the year 2000, I moved to Colorado, where I
worked as an Institute Scientist, and then Research
Associate Professor at the Eleanor Roosevelt Institute,
which was the only American research center that
participated in the sequencing of the human
Chromosome 21.  In that institution, I began to carry
out pharmacological studies on mouse models of Down
syndrome and started doing quantitative
neurophysiological assessments in persons with Down
syndrome.
In 2006, I became Associate Professor in the
Department of Medicine of the University of Colorado.
There, I began to design and run clinical trials in persons
with Down syndrome, and to attend regularly my
department’s clinical grand rounds.  Then, in 2011, I
became co-director of the Clinical Pharmacology
Course, which was an elective course taken by fourth
year medical students. My unexpected reunion with
the field of medicine, and my almost accidental
involvement in medical education, led me to countless
hours of reflection on the medical curriculum in the
United States in the 2010’s, on how it compared to the
education I had received in Brazil in the 1980s, and on
how the practice of medicine had changed as a result
of this spatiotemporal displacement.
For beginners, medicine in the United States is
a professional graduate-level school, which generally
follows a four-year college education that contains a
series of pre-medical prerequisite credits. After
graduation in medical school, the students receive the
title of doctor of medicine (medical doctor, or MD).  This
is followed by a one-year postdoctoral internship, then,
by residency training in a major medical specialty, and,
finally, by optional fellowship training; if such medical
doctor decides that he/she wants to pursue subspecialty
training.
In contrast, in Brazil (like in most countries in
the world) students go into medical school straight from
high school, which can partially be justified by
differences in high school education between the two
countries.  Back in the early 1980’s most Brazilian
medical students used to receive five years of classroom
medical school education, which helped narrow a little
bit the gap in years of formal education between the
countries.  This used to be followed by one year of pre-
doctoral internship, after which the student would
receive the professional physician title (the Brazilian
equivalent to an MD).  Similar to what happens in the
United States, newly minted physicians would then
pursue residency and, potentially, fellowship training.
It is actually sad to realize, however, that the so-
important fifth year of formal medical education has
now been deleted from the medical school curriculum,
and replaced with a second year of pre-doctoral
internship. The consequences of removing this fifth year
of education are difficult to quantify, but, given that
these students already got into medical school without
any previous college education, it is hard to believe
that this has had a positive effect. Perhaps the best
data supporting this assumption comes from the recent
report by the Regional Medical Board of São Paulo
(Conselho Regional de Medicina de São Paulo; http://
www.cremesp.org.br/?siteAcao=NoticiasC&id=3501),
which found that 55% of the newly-graduated
physicians in Brazil’s most powerful state failed to obtain
a passing grade (i.e., 60% correct answers on a test of
general medical knowledge) on the mandatory state
board exam.
In addition to the direct educational advantages
of medical school being a professional, graduate-level
course in the United States, because they are in average
four years older, in general, American medical students
are typically emotionally more mature then their
Brazilian counterparts. This is mostly noticeable in the
early years of training.
As a faculty member at the University of
Colorado, I became familiar with an interesting ritual
that exemplifies the maturity of the first year American
medical students.  At the end of the first year of medical
school, the students had the opportunity to participate
in a social ceremony where they would meet with the
family members of donor cadavers they dissected as
part of their Human Anatomy training. Seeing how those
first-year students approached this, could only bring
shame to me, as I remembered the immature 18-year
old me finishing my first year of medical school and
my complete lack of regard for the personal history of
cadavers that I had the privilege of dissecting…
In 2013, I moved to Case Western Reserve
University, Ohio.  Today, I am Professor of Pediatrics
and Psychiatry, and Director of the Intellectual Disability
Program at The Research Institute for Children’s Health
(RICH).  At this stage of my career, I have become
more and more involved in the field of Translational
Medicine.  My focus continues to be the search for
potential therapies to improve cognition and potentially
slow down the progression of neurodegeneration in
persons with Down syndrome.  In this capacity, I get
to design and perform both preclinical studies in animal
models and clinical trials in human participants.
In dealing with the intricacies associated with
the effective and ethical translation of laboratory data
into potentially clinically relevant information,
frequently, I catch myself reflecting on or even debating
certain issues that had been long dormant in my brain,
such as history of medicine, medical education in the
21st century, and the current state and the future of
clinical practice.  This is because, whether I like to admit
it or not, Translational Medicine is a form of medicine.
And, over the past decade, little by little, I have become
a practitioner of this non-traditional type of medicine.
Translational Medicine is a discipline within the
realms of biomedical research and public health aimed
at improving the health of individuals and the
community3. The Institute of Medicine’s Clinical
Research Roundtable helped define this field through
the description of two “translational blocks” in the
clinical research enterprise, which were later labeled
as T1 and T2. The first roadblock (T1) was described
as “the transfer of new understandings of disease
mechanisms gained in the laboratory into the
development of new methods for diagnosis, therapy,
and prevention and their first testing in humans.” The
second roadblock (T2) was “the translation of results
from clinical studies into everyday clinical practice and
health decision making.” By translating scientific
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findings into diagnostic tools, therapies, procedures,
policies, and education, translational medicine has
rapidly grown in its ability to accelerate discovery.
In the field of translational medicine, I have
encountered something that I find both meaningful and
rewarding, and it fits almost perfectly my professional
training. Translational Medicine provides the clinically
relevant research necessary to inform the practice of
Evidence Based Medicine. Unfortunately, however,
many fail to recognize that the methods and goals of
Translational Medicine do not always coincide with those
of Evidence Based Medicine.
When a researcher designs a clinical study,
frequently, the goal is to test whether a given therapy
shifts positively the mean value of the primary efficacy
outcome measure in a group of treated participants
compared with a placebo or standard-treatment group.
Ideally, the study is designed in such way that neither
those administering the therapy nor those receiving
the therapy know what treatment is being administered
(i.e., double blind study). In addition, it is important
that the sample size is large enough to give the study
enough statistical power to allow reasonable
generalizations of the study findings to the entire
population of individuals affected by the disorder or
disease for which one hopes to find a treatment. If the
study is successful, the investigators will report the
finding that the treatment positively and significantly
affected the mean value of the primary efficacy outcome
measure, with minimal adverse events. Therefore, it
can be argued that clinical investigators are trying to
“treat the mean” of their study subjects.  In contrast,
a physician in clinical practice is interested in treating
“the individual patient” in his/her practice. There are
many other important differences, which are
determined by the clinical study design. For example,
to avoid potential confounders, clinical investigators
will establish a set of a priori inclusion and exclusion
criteria for participation in a clinical trial, which
somewhat “homogenizes the sample”. In everyday
practice, however, a physician typically has little choice
but to try to offer treatment to all patients, whether or
not they fit neatly into the confines of the design of the
study that led to the approval of such treatment in the
first place. Although many other differences and
limitations could be listed here, doing so would go
beyond the scope of the present text. Suffice to say
that failure to recognize the limitations of even the
best-designed clinical studies in terms of their
usefulness to day-to-day clinical practice, which
necessarily should deal with individual variations, often
lead to distortions and excesses in the application of
the principles of Evidence Based Medicine.
Discontentment with the current state of affairs,
which has been voiced by many practitioners in recent
years, was described eloquently in a recent op-ed
published by the cardiologist Dr. Sandeep Jauhar in
the New York Times in December 10, 2014 (http://
www.nyt imes.com/2014/12/11/opinion/dont-
homogenize-health-care.html?_r=0), with the
headline: “Don’t Homogenize Health Care.” He starts
his text by saying that in “American medicine today,
“variation” has become a dirty word. Variation in the
treatment of a medical condition is associated with
wastefulness, lack of evidence and even capricious
care.” He then goes on to describe how insurers and
medical specialty societies have joined forces “to
produce a dizzying array of treatment guidelines for
everything from asthma to diabetes, from urinary
incontinence to gout.”  He admits that “some types of
variation are unwarranted, even deadly”, and even cites
data indicating that “57,000 Americans die each year
because the care they get is not based on the best
available evidence.”  Then, he reasons, “the effort to
homogenize health care presumes that we always know
which treatments are best and should be applied
uniformly.”  However, as he contends, “evidence for
most treatments in medicine remains weak. In the
absence of good evidence recommending one treatment
over another, trying to stamp out variation in care is
irrational.”
One of the unintended consequences of the
almost blind reliance on published evidence over the
kind of professional common sense acquired through
many years of clinical practice that used to be the main
guide of physicians in the past is an overall sense of
loss of autonomy in the medical profession. Formerly,
clinical knowledge used to be king, but, presently,
published evidence, from clinical trial results and meta-
analyses, is the new king! Are we ever going to abolish
monarchy in medicine?
Many physicians see the growing number of
treatment guidelines, along with the dwindling
compensation for time spent with the patient, as limiting
factors to their professional freedom. In the United
States, physicians are frustrated with the profession in
numbers never seen historically. A 2010 survey by The
Physicians Foundation4, found that 40% of practicing
physicians considered quitting patient care in the next
1-3 years, either by retiring or seeking a non-clinical
job in healthcare, or seeking a job or business outside
of healthcare. However, it should be mentioned that,
as pointed by the authors of the survey, “historically,
physician dissatisfaction has not been a major
contributing factor to physician attrition.” Nevertheless,
there also has been a well-documented increase in the
rate of physician burnout, which is characterized
primarily by work-related emotional exhaustion. A
recent analysis of correlates of physician burnout across
regions and specialties, identified autonomy at the
workplace as the strongest correlate to work
engagement5. Accordingly, practitioners in outpatient
specialties in managed care systems may experience
negative health states due to the highly regulated
environment, which limits their autonomy, decision
making and ability to develop lasting professional
relationships with patients6. Physician burnout has been
associated with affective disorders, alcoholism, and
substance abuse, which are all common psychiatric
diagnoses among physicians who commit suicide. It
has been estimated that, on average, 400 physicians
in the United States commit suicide each year (the
equivalent of an entire medical school per year; http:/
/emedicine.medscape.com/article/806779).
I am fortunate to be a faculty member in two
clinical departments at Case Western Reserve University
(CWRU) School of Medicine, an institution that, for
more than 160 years, has earned an international
reputation for excellence in medical education and
research. In addition, CWRU School of Medicine has
been at the forefront of the development of medical
curricula for almost 70 years. Three CWRU School of
Medicine educators (Drs. Joseph T. Wearn, T. Hale Ham,
and John L. Caughey, Jr.) were recipients of the
Association of American Medical Colleges’ Abraham
Flexner Award for Distinguished Service to Medical
Education for developing and implementing the 1952
curriculum; and Dr. Frederick C. Robbins won the
Flexner award in recognition of his educational
leadership. The 1962 paper published by the New
England Journal of Medicine describing the CWRU
School of Medicine’s then new curriculum7 gave rise to
what is now known as the major curriculum “revolution”
of 1952. It originated the integrated organ systems
approach, which enables meaningful interdisciplinary
learning of themes rather than scattered disciplinary
factual medical knowledge8. In the subsequent decades,
this approach was adopted by most major universities
across the world, including the Federal University of
Rio de Janeiro (UFRJ).  However, as aforementioned,
my alma mater, the State University of Rio de Janeiro
(UERJ) was one of the slow adopters of the major
curriculum “revolution” of 1952. The UERJ was also
slow at fully supporting basic biomedical research.
Consequently, and unfortunately, this medical school
saw a steady decline of national prestige from the final
decade of the 20th century into the first decade of the
21st century.
CWRU School of Medicine is now one of a dozen
of leading American medical school involved on a
national effort to design and implement a new “medical
curriculum revolution for the 21st century”.  This new
curriculum is supposed to make heavy use of
technological tools, as well as producing more
collaborative physicians, who can be at ease discussing
clinical cases and therapeutic strategies among peers
of their subspecialty, as well as with members of
different medical specialty, basic scientists, and
members of completely different disciplines.  For
example, through an exciting partnership with Microsoft
Corporation, CWRU School of Medicine is pioneering
the teaching of human anatomy through the use of
HoloLens (http://case.edu/hololens/). Therefore, when
it is inaugurated in 2019, our new medical education
building will be at the core of one of the very first
cadaver-free medical schools in the United States.
As I wind down this narrative, it may have
become apparent to the reader of this editorial that I
am ambivalent about many new developments in the
teaching and practices of medicine. My perspective on
the subject is obviously different from the average
physician, as I do not have to endure daily clinical
practice. Also, I am now old enough that I may have
started to romanticize a medical training that was truly
traumatic at the time. However, like many others of
my generation, I see a progressive loss of the human
dimension in the modern practice of medicine as a
problem to be addressed. Buzzwords like “personalized
medicine” (which, recently, is starting to be replaced
by “precision medicine”) can be quite empty in meaning
if the human person with all his/her idiosyncrasies,
dimensions, and “inconvenient variations” is not
brought back to the fore of our profession.
Although I loathed every single minute I spent
dissecting cadavers in anatomy class, I also feel it was
a necessary introduction to the frequent encounters
between the physician and the finality of human life.
Such introduction served me very well when, years later,
I “lost” my first patient while moonlighting in the
Emergency Room as a senior medical student. It was
only after 25 years, however, in a distant medical school
in my new, adopted home country that I was finally
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which recognizes the value of people’s narratives in
clinical practice, research and education.  At its core,
Narrative Medicine aims not only at validating the
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shorter time that the typical physician is expected to
spend with his/her patient. Still, movements such as
Narrative Medicine give me hope that the practice of
medicine will continue to evolve, but it will not forget
its roots.
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